BioTelemetry Inc. Announces CE Mark Approval of Holter Analysis Software

BioTelemetry, CE Mark, Holter analysis software

September 27, 2016 — BioTelemetry Inc. announced in late August that the company has received CE mark approval of its Holter analysis software. The software can be used either on a stand-alone basis or in combination with the company’s family of digital Holter recorders.

BioTelemetry President and CEO Joseph H. Capper said the company expects to launch an integrated solution with the newly acquired ePatch device (acquired from Delta Danish Electronics, Light & Acoustics in April) in the near future. The Holter software currently operates with BioTelemetry’s legacy Holter recorders.

The company expects to market the Holter analysis software under the Millennia brand name.

For more information: www.gobio.com

Related Content

. Leading the charge are devices like the Eko smart stethoscope and the Tyto remote otoscope that allow clinicians to remotely auscultate patients’ hearts, lungs and abdomen, and see inside the ear. More devices will surely come, with the aim of replicating the in-office visit.

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

The Future of Cardiac Health

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

May 04, 2022

AI system is trained to read conventional retinal scans for signs of heart disease

News | Cardiac Diagnostics

AI Can Diagnose Heart Disease By Looking In the Eye of the Patient

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

January 31, 2022

An Abbott Vascular survey found one in four physicians surveyed feel lack of technology makes an accurate diagnosis of coronary artery disease and peripheral artery disease a key obstacle to an accurate diagnosis. Getty Images

News | Cardiac Diagnostics

Research Finds Challenges in Vascular Disease Symptom Recognition and Diagnostic Testing Impacts Patient Satisfaction

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

November 10, 2021

Cardiac CT Given Strong Recommendation as Front-line Imaging of Chest Pain, but the American Society of Nuclear Cardiology (ASNC) did not support the guidelines.

Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

First International Chest Pain Diagnosis Guidelines Released

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

October 29, 2021

SimpleSense is an FDA cleared remote diagnostic platform. The cloth-based nanosensor technology undergarment monitors multiple patient vitals such as heart rate, blood pressure, respiration rate, and physical activity.

News | Cardiac Diagnostics

FDA Clears Nanowear Platform to Implement AI-based Home Diagnostics and Monitoring Network

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

October 04, 2021

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a personal medical device kit, Biokit, that includes a bundled of home-use devices to monitor cardiovascular disease. It includes a digital thermometer, a pulse oximeter and a blood pressure cuff. All three devices are U.S. FDA cleared, wireless, wearable, and integrate into the Biotricity ecosystem, a platform for interconnectivity.

News | Cardiac Diagnostics

Biotricity Releases Biokit With Three Home Monitoring Devices for Cardiac Disease Management

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

September 28, 2021

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device.

News | Cardiac Diagnostics

Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

July 29, 2021

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics

FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

July 01, 2021

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

News | Cardiac Diagnostics

Detecting Heart Disease Through an Eye Exam

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

March 08, 2021

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

News | Cardiac Diagnostics

AliveCor Collaborates With AstraZeneca to Develop Noninvasive Potassium Monitoring Solutions

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

March 03, 2021